Skip to the page

Data / Form D filings / Ingenia Therapeutics Inc.

Ingenia Therapeutics Inc.: Form D filings

Ingenia Therapeutics Inc., a biotechnology company in Watertown, MA, filed 4 Form D notices with the SEC between 2019 and 2024. The latest, on June 21, 2024, reports $5 million sold of a $25 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
134 COOLIDGE AVENUE, BIOLABS 2ND FLOOR, Watertown, MA, 02472
Phone
(781) 491-9005
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1796831

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 21, 2024New notice$25,000,000$5,000,000$20,000,0001Jun 12, 2024sec.gov
Nov 30, 2022New notice$16,007,866$7,007,866$9,000,0005Nov 18, 2022sec.gov
Sep 29, 2020New notice$5,707,530$4,707,530$1,000,0009Sep 25, 2020sec.gov
Dec 13, 2019New notice$5,000,000$100,000$4,900,0001Nov 29, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sang Gyun KimDirector
Eric FurfineDirector
Joo Hee KwakDirector
Sangyeul HanExecutive Officer, Director
Kwang Ho CheongDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jun 17, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Ingenia Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.